Executive summary: International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: A 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases

Clinical Infectious Diseases

Volumn 52, Issue 5, 2011, Pages 561-564

  Gupta, Kalpana ^a   Hooton, Thomas M ^b   Naber, Kurt G ⁱ   Wullt, Björn ^j   Colgan, Richard ^c   Miller, Loren G ^d   Moran, Gregory J ^e   Nicolle, Lindsay E ^h   Raz, Raul ^k   Schaeffer, Anthony J ^f   Soper, David E ^g  

^a VA BOSTON HEALTHCARE SYSTEM   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^d HARBOR UCLA MEDICAL CENTER   (United States)

^e UCLA MEDICAL CENTER   (United States)

^f NORTHWESTERN UNIVERSITY   (United States)

^g MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^h UNIVERSITY OF MANITOBA   (Canada)

ⁱ TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^j LUND UNIVERSITY HOSPITAL   (Sweden)

^k HAEMEK MEDICAL CENTER   (Israel)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; BETA LACTAM ANTIBIOTIC; CEFACLOR; CEFALEXIN; CEFDINIR; CEFPODOXIME PROXETIL; CEFTRIAXONE; CIPROFLOXACIN; COTRIMOXAZOLE; FOSFOMYCIN TROMETAMOL; LEVOFLOXACIN; NITROFURANTOIN; OFLOXACIN; PIVMECILLINAM; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SULFADOXINE PLUS TRIMETHOPRIM;

ACUTE UNCOMPLICATED CYSTITIS; ANTIMICROBIAL THERAPY; ARTICLE; CYSTITIS; FEMALE; HUMAN; IN VITRO STUDY; MEDICAL SOCIETY; PRACTICE GUIDELINE; PREMENOPAUSE; PREVALENCE; PRIORITY JOURNAL; PYELONEPHRITIS; SINGLE DRUG DOSE; UNSPECIFIED SIDE EFFECT; URINARY TRACT INFECTION;

EID: 79951847357     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cir102     Document Type: Article

References (11)

1. Warren JW, Abrutyn E, Hebel JR, Johnson JR, Schaeffer AJ, Stamm WE. Guidelines. for antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelone (Pubitemid 30256361)
2. Huang ES, Stafford RS. National patterns in the treatment of urinary tract infections in women by ambulatory care physicians. Archives of internal medicine 2002;162:41-7. (Pubitemid 34073399)
3. Kahan NR, Chinitz DP, Kahan E. Longer than recommended empiric antibiotic treatment of urinary tract infection in women: an avoidable waste of money. Journal of clinical pharmacy and therapeutics 2004;29:59-63. (Pubitemid 38253538)
4. Kallen AJ, Welch HG, Sirovich BE. Current antibiotic therapy for isolated urinary tract infections in women. Archives of internal medicine 2006;166:635-9.
5. O'Connor PJ, Solberg LI, Christianson J, Amundson G, Mosser G. Mechanism of action and impact of a cystitis clinical practice guideline on outcomes and costs of care in an HMO. The Joint Commission journal on quality improvement 1996;22:673-82.
6. Stamm WE. Evaluating guidelines. Clin Infect Dis 2007;44:775-6. (Pubitemid 46365299)
7. Fosfomycin for urinary tract infections. Med Lett Drugs Ther 1997;39:66-8. PMID: 9255237.
8. Kahlmeter G. An international survey of the antimicrobial susceptibility of pathogens from uncomplicated urinary tract infections: the ECO. SENS Project. J Antimicrob Chemother 2003;51:69-76. (Pubitemid 36163829)
9. Kahlmeter G. Prevalence and antimicrobial susceptibility of pathogens in uncomplicated cystitis in Europe. The ECO. SENS study. Int J Antimicrob Agents 2003;22(Suppl. 2): 49):49-52.
10. Naber KG, Schito G, Botto H, Palou J, Mazzei T. Surveillance study in Europe and Brazil on clinical aspects and Antimicrobial Resistance Epidemiology in Females with Cystitis (ARESC): implications for empiric therapy. Eur Urol 2008;54:1164-75.
11. Zhanel GG, Hisanaga TL, Laing NM, et al. Antibiotic resistance in Escherichia coli outpatient urinary isolates: final results from the North American Urinary Tract Infection Collaborative Alliance (NAUTICA). Int J Antimicrob Agents 2006;27:468-75.